Answers are grounded in this paper and cite their sources.
Crizotinib reversed ABCB1-mediated MDR by inhibiting ABCB1 transport function without affecting ABCB1 expression or blocking the Akt or ERK1/2 pathways. These findings are useful for planning combination chemotherapy of crizotinib with conventional chemotherapeutic drugs.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: